AIMS/HYPOTHESIS: In women who are overweight or obese before or during pregnancy there is an associated risk of increased fetal growth and higher birthweight. The metabolic phenotype of the overweight/obese pregnant woman, characterised by higher than normal insulin resistance (IR) and increased circulating fuels, suggests a mechanism resulting in fetal overnutrition and subsequent increased adiposity. We tested the fuel-mediated hypothesis in an observational pre-birth cohort of 951 mother-offspring pairs, the Healthy Start study. METHODS: We conducted a path analysis to estimate the simultaneous effects of maternal IR and maternal fuels (fasting glucose, triacylglycerol [TG] and NEFA levels) in late pregnancy in mediating the relationship between maternal pre-pregnancy BMI and neonatal adiposity (per cent fat mass [%FM]). RESULTS: The total effect of maternal BMI on neonatal %FM was significant (total effect 0.16, 95% CI 0.08, 0.22, p < 0.001). The mediated path including maternal IR and glucose levels together accounted for 21% (p < 0.01) of the total effect of maternal BMI on neonatal %FM while the mediating effects of all other fuels were non-significant. CONCLUSIONS/ INTERPRETATION: Using a novel application of path analysis our data implicate maternal IR and glucose levels as important mediators of the association between maternal and infant adiposity.
AIMS/HYPOTHESIS: In women who are overweight or obese before or during pregnancy there is an associated risk of increased fetal growth and higher birthweight. The metabolic phenotype of the overweight/obese pregnant woman, characterised by higher than normal insulin resistance (IR) and increased circulating fuels, suggests a mechanism resulting in fetal overnutrition and subsequent increased adiposity. We tested the fuel-mediated hypothesis in an observational pre-birth cohort of 951 mother-offspring pairs, the Healthy Start study. METHODS: We conducted a path analysis to estimate the simultaneous effects of maternal IR and maternal fuels (fasting glucose, triacylglycerol [TG] and NEFA levels) in late pregnancy in mediating the relationship between maternal pre-pregnancy BMI and neonatal adiposity (per cent fat mass [%FM]). RESULTS: The total effect of maternal BMI on neonatal %FM was significant (total effect 0.16, 95% CI 0.08, 0.22, p < 0.001). The mediated path including maternal IR and glucose levels together accounted for 21% (p < 0.01) of the total effect of maternal BMI on neonatal %FM while the mediating effects of all other fuels were non-significant. CONCLUSIONS/ INTERPRETATION: Using a novel application of path analysis our data implicate maternal IR and glucose levels as important mediators of the association between maternal and infant adiposity.
Authors: Francisco Visiedo; Fernando Bugatto; Viviana Sánchez; Irene Cózar-Castellano; Jose L Bartha; Germán Perdomo Journal: Am J Physiol Endocrinol Metab Date: 2013-05-14 Impact factor: 4.310
Authors: Holly R Hull; Mary K Dinger; Allen W Knehans; David M Thompson; David A Fields Journal: Am J Obstet Gynecol Date: 2008-02-15 Impact factor: 8.661
Authors: Kristin A Harmon; Lori Gerard; Dalan R Jensen; Elizabeth H Kealey; Teri L Hernandez; Melanie S Reece; Linda A Barbour; Daniel H Bessesen Journal: Diabetes Care Date: 2011-07-20 Impact factor: 19.112
Authors: Lynn P Lowe; Boyd E Metzger; Alan R Dyer; Julia Lowe; David R McCance; Terence R J Lappin; Elisabeth R Trimble; Donald R Coustan; David R Hadden; Moshe Hod; Jeremy J N Oats; Bengt Persson Journal: Diabetes Care Date: 2012-02-01 Impact factor: 19.112
Authors: Izzuddin M Aris; Shu E Soh; Mya Thway Tint; Shen Liang; Amutha Chinnadurai; Seang Mei Saw; Victor S Rajadurai; Kenneth Kwek; Michael J Meaney; Keith M Godfrey; Peter D Gluckman; Fabian K P Yap; Yap Seng Chong; Yung Seng Lee Journal: J Clin Endocrinol Metab Date: 2013-12-20 Impact factor: 5.958
Authors: Christine W Hockett; Kylie K Harrall; Brianna F Moore; Anne P Starling; Anna Bellatorre; Katherine A Sauder; Wei Perng; Ann Scherzinger; Kavita Garg; Brandy M Ringham; Deborah H Glueck; Dana Dabelea Journal: Diabetologia Date: 2019-08-23 Impact factor: 10.122
Authors: K A Sauder; A P Starling; A L Shapiro; J L Kaar; B M Ringham; D H Glueck; J A Leiferman; A M Siega-Riz; D Dabelea Journal: Diabet Med Date: 2016-03-03 Impact factor: 4.359
Authors: I-Lynn Lee; Elizabeth L M Barr; Danielle Longmore; Federica Barzi; Alex D H Brown; Christine Connors; Jacqueline A Boyle; Marie Kirkwood; Vanya Hampton; Michael Lynch; Zhong X Lu; Kerin O'Dea; Jeremy Oats; H David McIntyre; Paul Zimmet; Jonathan E Shaw; Louise J Maple-Brown Journal: Diabetologia Date: 2020-01-08 Impact factor: 10.122
Authors: Wei Perng; Brandy M Ringham; Harry A Smith; Gregory Michelotti; Katerina M Kechris; Dana Dabelea Journal: Diabetologia Date: 2019-11-13 Impact factor: 10.122
Authors: Katherine A Sauder; Traci A Bekelman; Kylie K Harrall; Deborah H Glueck; Dana Dabelea Journal: Pediatr Obes Date: 2019-07-05 Impact factor: 4.000
Authors: Stephanie R Wesolowski; Karim C El Kasmi; Karen R Jonscher; Jacob E Friedman Journal: Nat Rev Gastroenterol Hepatol Date: 2016-10-26 Impact factor: 46.802